778 Results.
Showing 1 to 10
|
Summary:
Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V On Drugs With The Active Ingredient Dasatinib (atc Code: L01ea02).
Sector:
Pharmaceuticals
Country:
Germany
Notice Type:
Tender Notice
Deadline:
28 Dec 2024
|
|
Summary:
Lfp - "dns For Pharmaceutical Goods 2017 To 2018"
Sector:
Pharmaceuticals
Country:
Czech Republic Estimated Cost:
CZK 3000000 Notice Type:
Tender Notice
Deadline:
09 Feb 2027
|
|
Summary:
Completion Of A Non-excl. Discount Agreement According To § 130c Para. 1 Sgb V To Mepolizumab Atc Code: R03dx09 For The Period From 03/01/2023 To 02/28/2025
Sector:
Pharmaceuticals
Country:
Germany
Notice Type:
Tender Notice
Deadline:
03 Jan 2025
|
|
Summary:
Completion Of A Non-excl. Discount Agreement According To § 130a Para. 8 Sgb V On Fentanyl Dihydrogen Citrate, Atc Code: N02ab03 For The Period From 03/01/2023 To 02/28/2025
Sector:
Pharmaceuticals
Country:
Germany
Notice Type:
Tender Notice
Deadline:
03 Jan 2025
|
|
Summary:
Completion of a non-excl. Discount agreement according to § 130c paragraph 1 SGB V for Elbasvir, Grazoprevir ATC code: J05AP54 for the period from 03/01/2023 to 02/28/2025
Sector:
Pharmaceuticals
Country:
Germany
Notice Type:
Tender Notice
Deadline:
03 Jan 2025
|
|
Summary:
Conclusion of non-exclusive drug discount agreements according to § 130a Para. 8 SGB V by means of a so-called open house model for the active ingredient etanercept (ATC code according to WHO: L04AB01
Sector:
Pharmaceuticals
Country:
Germany
Notice Type:
Tender Notice
Deadline:
31 Mar 2025
|
|
Summary:
Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V On The Active Ingredient Telmisartan + Amlodipine, Atc C09db04 For The Period 03/01/2023 - 02/28/2025
Sector:
Pharmaceuticals
Country:
Germany
Notice Type:
Tender Notice
Deadline:
05 Jan 2025
|
|
Summary:
Dynamic Procurement System: Medicinal Products And Products Comparable To Them
Sector:
Pharmaceuticals
Country:
Finland
Notice Type:
Tender Notice
Deadline:
16 Jan 2027
|
|
Summary:
Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V On The Active Ingredient Colecalciferol + Sodium Fluoride, Atc A11cc80 For The Period 03/01/2023 - 02/28/2025
Sector:
Pharmaceuticals
Country:
Germany
Notice Type:
Tender Notice
Deadline:
05 Jan 2025
|
|
Summary:
Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Bempedoic Acid + Ezetimibe, Atc C10ba10 For The Period 03/01/2023 - 02/28/2025
Sector:
Pharmaceuticals
Country:
Germany
Notice Type:
Tender Notice
Deadline:
05 Jan 2025
|
Healthcare and Medicine